| P2093 | author name string | Medical Advisory Secretariat | |
| P2860 | cites work | What should the burden of proof be for acceptance of a new breast-cancer screening technique? | Q80794065 |
| | Full-field digital mammography | Q83828900 |
| | Grading quality of evidence and strength of recommendations | Q24562409 |
| | Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits | Q24651187 |
| | Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population | Q30440344 |
| | MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC) | Q33194158 |
| | Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma | Q33197133 |
| | Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition | Q33205307 |
| | Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging | Q33244418 |
| | Radiation effects on breast cancer risk: a pooled analysis of eight cohorts | Q34137574 |
| | Breast cancer risk among the survivors of atomic bomb and patients exposed to therapeutic ionising radiation | Q35150654 |
| | Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer | Q36611741 |
| | Radiation risk and mammographic screening of women from 40 to 49 years of age: effect on breast cancer rates and years of life | Q36620759 |
| | Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results | Q36716114 |
| | MRI in the early detection of breast cancer in women with high genetic risk. | Q36721174 |
| | Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study | Q36886783 |
| | Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer | Q37155253 |
| | Comparison of full-field digital mammography with screen-film mammography for cancer detection: results of 4,945 paired examinations | Q39560290 |
| | Clinical comparison of full-field digital mammography and screen-film mammography for detection of breast cancer | Q39612927 |
| | Screen-film mammography versus full-field digital mammography with soft-copy reading: randomized trial in a population-based screening program--the Oslo II Study | Q39685573 |
| | Diagnostic performance of digital versus film mammography for breast-cancer screening | Q39730356 |
| | Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women | Q44062229 |
| | Cancers detected and induced, and associated risk and benefit, in a breast screening programme. | Q50689578 |
| | Two-view screening and extending the age range: the balance of benefit and risk. | Q50711496 |
| | Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. | Q50748795 |
| | Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). | Q50761882 |
| | Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. | Q50772733 |
| | Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. | Q51798328 |
| | Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. | Q52069084 |
| | Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. | Q53256330 |
| | Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. | Q53275829 |
| | The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30–49 | Q57266710 |
| | Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer | Q74299619 |
| | Full-field digital mammography | Q74585976 |
| | Risk factors for induction of breast cancer by X-rays and their implications for breast screening | Q79233686 |
| | Breast cancer mortality after screening mammography in British Columbia women | Q79409039 |
| | Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series | Q79816994 |
| | Magnetic resonance imaging of the breast in screening women considered to be at high genetic risk of breast cancer | Q79822876 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mammography | Q324634 |
| | Digital mammography | Q5276102 |
| P304 | page(s) | 1-55 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Ontario health technology assessment series | Q27722839 |
| P1476 | title | Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis | |
| P478 | volume | 10 | |